Blue Cross and Blue Shield of Kansas (BCBSKS) began preparing for gene therapy requests back in 2017, when Luxturna® (voretigene neparvovec-rzyl) was approved. At the time,…
At Prime Therapeutics (Prime), we’ve positioned ourselves to best prepare our clients to manage new drugs. Our clinical and trade relations teams keep a keen…
Drug name: vosoritide Manufacturer: BioMarin Condition: Achondroplasia in children from age 2 until growth plates close (typically under 18 years of age) Condition overview:¹²³ Achondroplasia…
